Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker SGMOQ
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Oct 27, 2026 | SGMOQ Sangamo Therapeutics, Inc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 16, 2026 | SGMOQ Sangamo Therapeutics, Inc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 21, 2026 | SGMOQ Sangamo Therapeutics, Inc | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Sep 21, 2026 | SGMOQ Sangamo Therapeutics, Inc | 1.03 Bankruptcy or Receivership | 8-K | 8-K ↗ |
| Sep 8, 2026 | SGMOQ Sangamo Therapeutics, Inc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 8, 2026 | SGMOQ Sangamo Therapeutics, Inc | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Sep 8, 2026 | SGMOQ Sangamo Therapeutics, Inc | 1.03 Bankruptcy or Receivership | 8-K | 8-K ↗ |
| Aug 28, 2026 | SGMOQ Sangamo Therapeutics, Inc | 1.03 Bankruptcy or Receivership | 8-K | 8-K ↗ |
| Aug 28, 2026 | SGMOQ Sangamo Therapeutics, Inc | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 13, 2026 | SGMOQ Sangamo Therapeutics, Inc | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 12, 2026 | SGMOQ Sangamo Therapeutics, Inc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 20, 2026 | SGMOQ Sangamo Therapeutics, Inc | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Jul 20, 2026 | SGMOQ Sangamo Therapeutics, Inc | 1.03 Bankruptcy or Receivership | 8-K | 8-K ↗ |
| Jul 1, 2026 | SGMOQ Sangamo Therapeutics, Inc | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 1, 2026 | SGMOQ Sangamo Therapeutics, Inc | 4.01 Changes in Registrant's Certifying Accountant | 8-K | 8-K ↗ |
| Jun 23, 2026 | SGMOQ Sangamo Therapeutics, Inc | 2.05 Costs Associated with Exit or Disposal Activities | 8-K | 8-K ↗ |
| Jun 23, 2026 | SGMOQ Sangamo Therapeutics, Inc | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Jun 23, 2026 | SGMOQ Sangamo Therapeutics, Inc | 1.03 Bankruptcy or Receivership | 8-K | 8-K ↗ |
| Jun 23, 2026 | SGMOQ Sangamo Therapeutics, Inc | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 14, 2026 | SGMOQ Sangamo Therapeutics, Inc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 29, 2026 | SGMOQ Sangamo Therapeutics, Inc | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Mar 30, 2026 | SGMOQ Sangamo Therapeutics, Inc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 4, 2026 | SGMOQ Sangamo Therapeutics, Inc | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Feb 4, 2026 | SGMOQ Sangamo Therapeutics, Inc | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 3, 2026 | SGMOQ Sangamo Therapeutics, Inc | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 3, 2026 | SGMOQ Sangamo Therapeutics, Inc | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Feb 3, 2026 | SGMOQ Sangamo Therapeutics, Inc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 6, 2025 | SGMOQ Sangamo Therapeutics, Inc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 29, 2025 | SGMOQ Sangamo Therapeutics, Inc | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Sep 30, 2025 | SGMOQ Sangamo Therapeutics, Inc | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Sep 11, 2025 | SGMOQ Sangamo Therapeutics, Inc | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Sep 4, 2025 | SGMOQ Sangamo Therapeutics, Inc | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 7, 2025 | SGMOQ Sangamo Therapeutics, Inc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 24, 2025 | SGMOQ Sangamo Therapeutics, Inc | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 16, 2025 | SGMOQ Sangamo Therapeutics, Inc | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 16, 2025 | SGMOQ Sangamo Therapeutics, Inc | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 13, 2025 | SGMOQ Sangamo Therapeutics, Inc | 8.01 Other Events | 8-K | 8-K ↗ |
| May 6, 2025 | SGMOQ Sangamo Therapeutics, Inc | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Mar 17, 2025 | SGMOQ Sangamo Therapeutics, Inc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 6, 2025 | SGMOQ Sangamo Therapeutics, Inc | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 30, 2024 | SGMOQ Sangamo Therapeutics, Inc | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 10, 2024 | SGMOQ Sangamo Therapeutics, Inc | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 10, 2024 | SGMOQ Sangamo Therapeutics, Inc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 12, 2024 | SGMOQ Sangamo Therapeutics, Inc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
44 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 8:04 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances